Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

FUSN

Fusion Pharmaceuticals Inc

Nov 28 • 01:53PM ET

4.62

Dollar change -0.08
Percentage change -1.70	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.63	Insider Own	30.55%	Shs Outstand	72.41M	Perf Week	3.59%
Market Cap	334.53M	Forward P/E	-	EPS next Y	-1.40	Insider Trans	0.00%	Shs Float	50.29M	Perf Month	14.64%
Income	-91.33M	PEG	-	EPS next Q	-0.35	Inst Own	47.22%	Short Float / Ratio	0.18% / 0.51	Perf Quarter	45.28%
Sales	2.21M	P/S	151.37	EPS this Y	27.42%	Inst Trans	-3.23%	Short Interest	0.09M	Perf Half Y	6.94%
Book/sh	2.73	P/B	1.70	EPS next Y	3.85%	ROA	-37.14%	Target Price	12.30	Perf Year	116.39%
Cash/sh	2.65	P/C	1.74	EPS next 5Y	-	ROE	-49.16%	52W Range	2.06 - 5.63	Perf YTD	46.67%
Dividend	-	P/FCF	-	EPS past 5Y	-118.51%	ROI	-38.88%	52W High	-17.94%	Beta	-1.24
Dividend %	-	Quick Ratio	11.63	Sales past 5Y	0.29%	Gross Margin	-	52W Low	124.40%	ATR	0.43
Employees	102	Current Ratio	11.63	Sales Q/Q	1108.43%	Oper. Margin	-4319.47%	RSI (14)	57.62	Volatility	11.80% 10.50%
Optionable	Yes	Debt/Eq	0.28	EPS Q/Q	54.56%	Profit Margin	-4136.55%	Rel Volume	0.44	Prev Close	4.70
Shortable	Yes	LT Debt/Eq	0.25	Earnings	Nov 07 BMO	Payout	-	Avg Volume	182.15K	Price	4.62
Recom	1.08	SMA20	5.22%	SMA50	21.53%	SMA200	17.65%	Volume	54,960	Change	-1.70%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-29-23	Initiated	Oppenheimer	Outperform	$13
Jun-23-23	Initiated	Raymond James	Outperform	$13
Dec-01-22	Resumed	B. Riley Securities	Buy	$10
Nov-30-22	Initiated	SVB Leerink	Outperform	$6
Sep-16-22	Initiated	Truist	Buy	$10
Jul-06-22	Initiated	William Blair	Outperform
Oct-19-21	Resumed	Morgan Stanley	Overweight	$19
Aug-26-21	Initiated	B. Riley Securities	Buy	$17
Jul-21-20	Initiated	Wedbush	Outperform	$25
Jul-21-20	Initiated	Jefferies	Buy	$25
Jul-21-20	Initiated	Cowen	Outperform

Show Previous Ratings

Nov-27-23 09:55AM	How Much Upside is Left in Fusion Pharmaceuticals Inc. (FUSN)? Wall Street Analysts Think 162% (Zacks) -6.00%
Nov-16-23 06:45AM	Fusion Pharmaceuticals Strengthens Actinium Supply with Onsite Isotope Production through Expanded BWXT Medical Collaboration (PR Newswire)
06:45AM	BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology (Business Wire)
Nov-08-23 04:15PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
08:15AM	Fusion Pharmaceuticals to Present at Upcoming Investor Conferences (PR Newswire)
08:28AM	Loading…
Nov-07-23 08:28AM	Fusion Pharmaceuticals Inc (FUSN) Reports Q3 2023 Financial Results and Clinical Program Updates (GuruFocus.com)
08:25AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
Oct-16-23 07:50AM	Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors (PR Newswire)
Oct-12-23 07:45AM	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers (PR Newswire)
Sep-06-23 04:25PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) -7.61%
Sep-05-23 04:10PM	Fusion Pharmaceuticals to Present at Upcoming September Investor Conferences (PR Newswire)
Aug-14-23 07:55AM	10 Oversold Penny Stocks To Buy (Insider Monkey)
Aug-09-23 04:05PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Aug-08-23 08:15AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Loading…
07:00AM	Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
Aug-05-23 03:30PM	10 Oversold Canadian Stocks To Buy (Insider Monkey)
Jul-06-23 04:05PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) -5.02%
Jun-29-23 10:08AM	One Fusion Pharmaceuticals Insider Raised Stake By 370% In Previous Year (Simply Wall St.)
Jun-26-23 08:05AM	Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R (PR Newswire)
Jun-16-23 08:05AM	Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit (PR Newswire)
Jun-07-23 07:35AM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
May-31-23 04:10PM	Fusion Pharmaceuticals to Present at the Jefferies Healthcare Conference (PR Newswire) +18.06%
10:58AM	These 2 Strong Buy Penny Stocks Could Surge 200% (or More), Says Wedbush (TipRanks)
May-12-23 06:09AM	Fusion Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
May-11-23 07:15AM	Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
May-10-23 08:34AM	Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) has caught the attention of institutional investors who hold a sizeable 34% stake (Simply Wall St.) +7.45%
May-09-23 07:45AM	Fusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day (PR Newswire)
May-02-23 04:00PM	Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer (PR Newswire) -7.56%
Apr-20-23 04:15PM	Fusion Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference (PR Newswire) -8.92%
04:25PM	Loading…
Apr-19-23 04:25PM	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2059 and Leading Targeted Alpha Therapy Platform at AACR Annual Meeting (PR Newswire) -7.07%
Apr-13-23 09:47AM	Fusion (FUSN) to Begin Clinical Study on Targeted Alpha Therapy (Zacks)
Apr-12-23 04:05PM	Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy (PR Newswire)
Apr-05-23 04:10PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Mar-20-23 04:05PM	Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1 (PR Newswire)
Mar-16-23 08:45AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates (PR Newswire)
Mar-08-23 04:35PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Mar-02-23 04:35PM	Fusion Pharmaceuticals to Present at the 43rd Annual Cowen Healthcare Conference (PR Newswire) +6.11%
Feb-14-23 07:59AM	Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical (Benzinga) +22.10%
Feb-13-23 04:05PM	Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-PSMA I&T, a Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer (PR Newswire) +5.23%
08:05AM	Fusion Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference (PR Newswire)
Feb-07-23 04:10PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jan-20-23 08:33AM	A Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) insider increased their holdings by 370% last year (Simply Wall St.) -5.32%
Jan-06-23 07:45AM	Fusion Pharmaceuticals Reports Progress and Provides Recent Corporate Highlights (PR Newswire) +5.87%
Jan-05-23 05:00PM	Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies (PR Newswire) +8.07%
Jan-04-23 04:35PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +8.44%
Dec-22-22 09:52AM	2 Strong Buy Penny Stocks That Could Go Boom (TipRanks) +21.45%
Dec-07-22 04:15PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Nov-09-22 07:10AM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Nov-08-22 08:25AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +8.59%
07:00AM	Fusion Pharmaceuticals Announces Third Quarter 2022 Financial Results and Clinical Program Updates (PR Newswire)
Nov-07-22 04:25PM	Fusion Pharmaceuticals Appoints Dmitri Bobilev, M.D. as Chief Medical Officer (PR Newswire) -10.00%
Oct-28-22 07:11AM	Fusion Pharmaceuticals Inc.'s (NASDAQ:FUSN) largest shareholders are private equity firms with 37% ownership, institutions own 36% (Simply Wall St.)
Oct-13-22 12:00PM	What Makes Fusion Pharmaceuticals Inc. (FUSN) a New Strong Buy Stock (Zacks)
Oct-05-22 04:05PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Oct-04-22 01:15PM	10 Best Stocks to Buy Now According to Jeffrey Diehls Adams Street Partners (Insider Monkey)
Sep-27-22 11:11AM	Fusion Pharmaceuticals (NASDAQ:FUSN) shareholders have endured a 62% loss from investing in the stock a year ago (Simply Wall St.)
Sep-13-22 04:45PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Sep-08-22 10:42AM	Pacira (PCRX) Up on Data From Exparel Label Expansion Study (Zacks)
Sep-07-22 08:30AM	Fusion Pharmaceuticals to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (PR Newswire)
Aug-29-22 08:45AM	Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3 (PR Newswire)
Aug-13-22 08:09AM	Insider Buying: The Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Independent Director Just Bought 370% More Shares (Simply Wall St.)
Aug-12-22 09:35AM	After Plunging 14.9% in 4 Weeks, Here's Why the Trend Might Reverse for Fusion Pharmaceuticals Inc. (FUSN) (Zacks) +7.00%
Aug-09-22 08:25AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.85%
07:00AM	Fusion Pharmaceuticals Announces Second Quarter 2022 Financial Results and Clinical Program Updates (PR Newswire)
Aug-03-22 10:00AM	Gain Therapeutics, Inc. (GANX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Aug-02-22 04:45PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
10:00AM	Will Fusion Pharmaceuticals Inc. (FUSN) Report Negative Q2 Earnings? What You Should Know (Zacks)
Jul-29-22 06:24AM	We're Keeping An Eye On Fusion Pharmaceuticals' (NASDAQ:FUSN) Cash Burn Rate (Simply Wall St.)
Jul-07-22 07:55AM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jun-30-22 09:02AM	Top 10 Stock Picks of Jeffrey Diehls Adams Street Partners (Insider Monkey)
Jun-23-22 07:45AM	Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1 (PR Newswire) -16.00%
Jun-14-22 04:25PM	Fusion Pharmaceuticals Presents Imaging Data from Cold Antibody Sub-Study in the Phase 1 Study of FPI-1434 (PR Newswire)
Jun-10-22 07:42AM	Fusion Pharmaceuticals and Niowave Announce Actinium-225 Collaboration and Supply Agreement (PR Newswire)

Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FUSN

Fusion Pharmaceuticals Inc

Upgrade your FINVIZ experience